METlung_3A: METlung, figure 3A

METlung_3AR Documentation

METlung, figure 3A

Description

Kaplan-Meier digitized data from METlung, figure 3A (PMID 27937096). A reported sample size of 499 for a primary endpoint of OS in lung cancer.

Usage

METlung_3A

Format

A data frame of 499 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (onaturzumab_erlotinib, placebo_erlotinib)

Source

Spigel DR, Edelman MJ, O’Byrne K, et al. Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung. J Clin Oncol 2017; 35: 412–20.

Examples

summary(METlung_3A)

kmplot(METlung_3A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.